Latest News in the pharma Industry

Research & Development

New survival data for nivolumab in head and neck cancer

New survival data for nivolumab in head and neck cancer

19 Apr 2016

Phase III data for nivolumab in head and neck cancer show biggest increase in survival for 20 years.

Read more 
Protein research offers ”promising” potential treatment of Alzheimer’s disease

Protein research offers ”promising” potential treatment of Alzheimer’s disease

19 Apr 2016

Read more 
Innovations in proteomics and genomics drive era of precision medicine

Innovations in proteomics and genomics drive era of precision medicine

18 Apr 2016

Broad spectrum of technological advances for cancer research on display at AACR 2016.

Read more 
Seattle Genetics highlights novel ADC technology advances at AACR

Seattle Genetics highlights novel ADC technology advances at AACR

18 Apr 2016

Innovative research demonstrates Seattle Genetics’ leadership in empowered antibodies.

Read more 
Merck announces results from Phase III studies of Zepatier in chronic hepatitis C patient populations

Merck announces results from Phase III studies of Zepatier in chronic hepatitis C patient populations

17 Apr 2016

Data from these additional Phase III studies were presented at The International Liver Congress 2016.

Read more 
Shire Submits NDA to FDA for new formulation of Vyvanse CII as chewable tablets

Shire Submits NDA to FDA for new formulation of Vyvanse CII as chewable tablets

15 Apr 2016

New formulation, in adherence with approved indications, intended for children, adolescents and adults with difficulty swallowing or opening capsules.

Read more 
Presage Biosciences extends research collaboration with Takeda to discover novel cancer drug combinations

Presage Biosciences extends research collaboration with Takeda to discover novel cancer drug combinations

14 Apr 2016

The agreement provides Takeda access to Presage’s proprietary CIVO technology platform to enable identification of novel oncology drug combinations in solid tumours.

Read more 
AmpliPhi Biosciences terminates collaboration agreement with Intrexon

AmpliPhi Biosciences terminates collaboration agreement with Intrexon

14 Apr 2016

Terminating the EEC allows AmpliPhi to take advantage of the rapid advancements being made in the field of synthetic biology.

Read more 
Arena Pharmaceuticals reports favorable results from Phase Ib multiple-ascending dose clinical trial of APD371

Arena Pharmaceuticals reports favorable results from Phase Ib multiple-ascending dose clinical trial of APD371

14 Apr 2016

APD371 is a highly selective and potent agonist of the cannabinoid 2 receptor with potential utility in the treatment of pain.

Read more 
AbbVie receives FDA accelerated approval of Venclexta (venetoclax) tablets

AbbVie receives FDA accelerated approval of Venclexta (venetoclax) tablets

13 Apr 2016

The first BCL-2 inhibitor in relapsed/refractory chronic lymphocytic leukemia patients with 17p deletion.

Read more 
PhotoPharmics announces new discovery may have a major impact on treating Parkinson’s disease through the eyes

PhotoPharmics announces new discovery may have a major impact on treating Parkinson’s disease through the eyes

12 Apr 2016

Recent discoveries about the eye’s involvement in Parkinson’s offer new hope to the millions of people who suffer from the disease.

Read more 
Despite its weak pipeline, schizophrenia market may benefit from drugs used in similar indications

Despite its weak pipeline, schizophrenia market may benefit from drugs used in similar indications

12 Apr 2016

Read more